Tumor mülleriano mixto heterólogo primario de trompa uterina / Mixed mullerian tumor heterologous primary horn uterine

El tumor mülleriano mixto maligno es una neoplasia inusual que corresponde al 0,1 % - 0,5 % de los tumores malignos ginecológicos. Se presenta el caso de paciente de 73 años de edad que consulta por dolor y tumoración pélvica. Es llevada a mesa operatoria con el diagnóstico de tumor de anexo uterino izquierdo. Se realizó histerectomía total, salpingooforectomía bilateral y omentectomía, más lavado peritoneal. El estudio histopatológico informa tumor mülleriano mixto maligno primario de trompa uterina izquierda. La inmunohistoquimica reportó inmunomarcaje en las células neoplásicas con vimentina, Q7, PAX8, Ki67 15 % y concluye como tumor mixto mülleriano. La enfermedad fue clasificada como en estadio III (FIGO) y se decide quimioterapia sistémica de manera coadyuvante. A los 19 meses posteriores a la cirugía la paciente se encuentra estable y sin muestras de recidiva.

The malignant mixed Mullerian Tumor is an unusual neoplasia which corresponds to the 0.1 - 0.5 % of gynecologic malignancies. The case of female patient of 73-year-old consulting by pain and pelvic tumor arises. It is carried to the operating table with the left uterine annex tumor Diagnostics. He was total hysterectomy, bilateral salpingo-oophorectomy and omentectomy, most peritoneal washing. The histopathological study advises Tumor Mullerian mixed malignant primary left uterine Horn. Immunohistochemistry reported immunomarking in neoplastic cells with vimentin, Q7, PAX8, Ki67 15 % and concludes as mixed Tumor, Mullerian. The disease was classified as stage III (FIGO), and decided way adjuvant systemic chemotherapy. 19 months after the surgery, the patient is stable and no signs of relapse.

Uterine carcinosarcoma/malignant mixed Mullerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy / 부인종양

No abstract available.

Blood thicker than water: A case report on familial ovarian cancer / Philippine Journal of Obstetrics and Gynecology

Reported is a case of a 43 year-old Gravida 3 Para 3 (3003) admitted due to progressive abdominal enlargement, weight loss and dyspnea. Admitting Impression was Ovarian New Growth, bilateral, malignant, with secondary Pleural Effusion. She underwent Total Abdominal Hysterectomy, with Bilateral Salpingooophorectomy, bilateral lymph node dissection, peritoneal fluid cytology, and infracolic omentectomy. Histopathology report showed a Malignant Mixed Mullerian Tumor of both ovaries with metastasis to the colorectal serosa. It is noteworthy that the patient has two siblings who succumbed to advanced stage ovarian cancer. This case report will discuss the possible hereditary genetic mutations involved in the development of familialovarian carcinoma.

Carcinossarcoma uterino: relato de um caso com invasão da bexiga, mimetizando mullerianose com transformação maligna / Carcinosarcoma of the uterus: report of a case with invasion of the urinary bladder, resembling mullerianosis with malignant transformation

Introdução: Os carcinossarcomas uterinos são neoplasias infrequentes, correspondendo a apenas 3-9 por cento de todas as neoplasias ginecológicas, representam 48 por cento de todos os sarcomas, e possuem incidência de 8,2 por 1 milhão mulheres/ano. As principais manifestações clínicas são o sangramento vaginal anormal em idade pós-menopausa e dor abdominal. Caracterizam-se morfologicamente por elementos epiteliais e estromais. Podem eventualmente invadir estruturas adjacentes, inclusive a bexiga urinária. Relato do caso: Apresentamos um caso de carcinossarcoma uterino com invasão de bexiga mimetizando mullerianose com transformação maligna. A paciente do sexo feminino de 69 anos apresentava hematuria macroscópica como queixa única. Durante a investigação diagnóstica, após cistoscopia com exame anatomopatológico, foi sugerida a hipótese de mullerianose com transformação benigna. A paciente foientão encaminhada para ressecção cirúrgica da neoplasia. Durante o procedimento cirúrgico, notou-se a existência deuma massa tumoral uterina que invadia a bexiga urinária, e, após análise anatomopatológica, mostrou tratar-se de umcarcinossarcoma uterino com invasão vesical. Conclusão: Manifestações incomuns em doenças com grande potencialde malignidade, além de retardar o processo diagnóstico, interferem diretamente no prognóstico do paciente.

Concurrent Diagnosis of Pulmonary Metastasis of Malignant Mixed Mullerian Tumor and Small Cell Lung Cancer / 결핵및호흡기질환

A patient who has multiple lung masses with a history of malignancy in organs other than the lung is more likely to be diagnosed with metastatic rather than primary lung cancer. Rarely, metastatic cancer can coexist with primary. We experienced a case of concurrent diagnosis of primary small cell lung cancer and pulmonary metastasis of uterine malignant mixed Mullerian tumor (MMMT). The patient was a 52-year-old female with femur fracture and multiple lung masses with a history of an operation for uterine MMMT. The small cell lung cancer was diagnosed by bronchoscopic biopsy. The central lung mass decreased after chemotherapy for small cell lung cancer but multiple peripheral masses increased. A percutaneous biopsy for one of peripheral masses revealed metastatic uterine MMMT. We suggest that we have to consider the possible presence of concomitant malignancies of different origins in one organ especially with patients who had a history of malignancy in another organ.

Concurrent Diagnosis of Pulmonary Metastasis of Malignant Mixed Mullerian Tumor and Small Cell Lung Cancer / 결핵및호흡기질환

A patient who has multiple lung masses with a history of malignancy in organs other than the lung is more likely to be diagnosed with metastatic rather than primary lung cancer. Rarely, metastatic cancer can coexist with primary. We experienced a case of concurrent diagnosis of primary small cell lung cancer and pulmonary metastasis of uterine malignant mixed Mullerian tumor (MMMT). The patient was a 52-year-old female with femur fracture and multiple lung masses with a history of an operation for uterine MMMT. The small cell lung cancer was diagnosed by bronchoscopic biopsy. The central lung mass decreased after chemotherapy for small cell lung cancer but multiple peripheral masses increased. A percutaneous biopsy for one of peripheral masses revealed metastatic uterine MMMT. We suggest that we have to consider the possible presence of concomitant malignancies of different origins in one organ especially with patients who had a history of malignancy in another organ.

Collision of Three Histologically Distinct Endometrial Cancers of the Uterus

A collision tumor is defined by the presence of two separate masses in one organ, which are pathologically distinct. We described a 70-yr-old patient who complained of abnormal vaginal bleeding with a collision tumor of the uterine corpus. The patient received total hysterectomy, bilateral salphingo-oophorectomy, bilateral pelvic-paraaortic lymphadenectomy, omentectomy, and intraperitoneal chemotherapy. The uterine corpus revealed three separate masses, which were located at the fundus, anterior and posterior wall. Each tumor revealed three pathologically different components, which were malignant mixed mullerian tumor, papillary serous carcinoma, and endometrioid adenocarcinoma. Among these components, only the papillary serous carcinoma component invaded the underlying myometrium and metastasized to the regional lymph node. Adjuvant chemotherapy and radiation therapy were performed. The patient is still alive and has been healthy for the last 8 yr. We have reviewed previously reported cases of collision tumors which have occurred in the uterine corpus.

The Ultrasound and MRI Findings of Uterine Adenofibroma: A Case Report

Adenofibroma is an extremely rare benign mullerian mixed tumor composed of epithelium and mesenchymal cells. Most uterine adenofibromas occur in the endometrium, but they rarely protrude into the vagina. To date, only a few such cases with the imaging findings have been reported. Therefore, we report here on the sonographic and magnetic resonance (MR) imaging findings of a case of endometrial adenofibroma protruding into the vaginal cavity in a 28-year-old woman. The uterine adenofibroma appeared as a large intracavitary echogenic mass containing multiple small internal cysts, and it was distending the vaginal cavity on transrectal sonography. T2- weighted MR images showed a large intracavitary mass with heterogeneous high signal intensity protruding into the vaginal cavity. On gadolinium-enhanced T1-weighted MR images, heterogeneous septa-like enhancement was noted in the mass. Although uterine adenofibroma is extremely rare, adenofibroma can be suggested as a possible diagnosis when an intracavitary uterine mass, with multiple internal small cystic components and enhancing septa-like structures, is protruding into the vaginal cavity on imaging.

Tumores müllerianos mixtos malignos uterinos / Uterine malignant mixed mullerian tumors

Los tumores müllerianos mixtos malignos o carcinosarcomas son neoplasias poco frecuentes y altamente agresivas que suelen presentarse en pacientes mayores de 60 años, generalmente en forma de metrorragia posmenopáusica y/o presencia de masas uterinas. Entre los factores de riesgo reconocidos está descrita la historia de irradiación previa del área pélvica. Presentamos 3 casos clínicos de pacientes diagnosticadas y tratadas de tumores müllerianos mixtos uterinos malignos, existiendo en todos ellos el antecedente de neoplasias que habían precisado radioterapia pélvica como parte de su tratamiento.

The malignant Mullerian mixed tumors are rare and highly aggressive, these tumors usually occur in women over 60 years and the most common clinical appearance is that of postmenopausal vaginal bleeding or the presence of uterine mass. As a risk factor is described the history of prior irradiation of the pelvic area. We reported the case of three patients with mullerian mixed tumors, in all these cases the patients have a history of cancer who required pelvic radiation as part of their treatment.

Extra genital heterologous malignant mixed mullerian tumor of primary peritoneal origin.

The case of an extragenital heterologous malignant mixed müllerian tumor (MMMT) of primary peritoneal origin occurring in a 76-year-old female is presented. A large tumor was seen between the uterus and rectosigmoid occupying the entire pelvis. The uterus, fallopian tubes and ovaries were uninvolved. The tumor was composed of carcinomatous areas showing endometrioid and serous papillary differentiation and sarcomatous areas showing cartilaginous differentiation. The extragenital primary MMMTs of the female peritoneum are thought to originate from the secondary müllerian system. This case is presented for its rarity. To the best our knowledge, this is the first case of extragenital MMMT of primary peritoneal origin in Indian literature.

[Mixed mullerian tumors of uterus - about 25 cases]

The malignant mixed mullerian tumours [MMMT] or carcinosarcoma of the uterus are rare tumours, they represent 1,4% of all uterine neoplasia. They are characterized historically by double components carcinomatous and sarcomatous. We performed a retrospective study about 25 cases of carcinosarcoma of the endometrium, collected in Salah Azaiz Institute over a period of 30 years going from 1970 to 2000. The mean patient age was 60 years, and 68% of patients were menopaused. The metrorrhagia was revealing in 66% of cases. Clinically, an abdominopelvic mass was found in 12% of the cases. The pathological diagnosis was done in 12 endometrial biopsies and 10 biopsies of the tumour exteriorisated by the cervix. Surgery is the mainstay of the treatment. The prognosis remains dismal

MR Findings of Extrauterine Mullerian Adenosarcoma Associated with Deep Pelvic Endometriosis

Extrauterine mullerian adenosarcoma is a very rare tumor and it is characterized by a benign glandular component and a low-grade sarcomatous stromal component. These tumors have been reported to arise from ovarian or extraovarian endometriosis. However, there are scant reports on the MR findings of extrauterine mullerian adenosarcoma arising from deep pelvic endometriosis. We describe here a case of a large infiltrating extrauterine mullerian adenosarcoma arising from recurrent deep pelvic endometriosis and we discuss its MR findings.

Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses / 浙江大学学报（英文版）（B辑：生物医学和生物技术）

<p><b>OBJECTIVE</b>To investigate the factors favoring a positive prognosis for advanced primary peritoneal carcinoma (PPC).</p><p><b>METHODS</b>Twenty-four cases meeting the criteria for PPC were analyzed retrospectively for the clinicopathologic profiles. Immunohistochemistry was used to determine the expressions of p53, Top2alpha, Ki-67 and Her-2/neu. Then all these clinicopathological factors and molecular markers were correlated with the prognosis.</p><p><b>RESULTS</b>There were 15 cases of primary peritoneal serous papillary carcinoma (PPSPC), 6 cases of mixed epithelial carcinoma (MEC) and 3 cases of malignant mixed Mullerian tumor (MMMT). All patients underwent cytoreductive surgery with optimal debulking achieved in 3 cases. Among those receiving first-line chemotherapy, 13 patients received the TP regimen (paclitaxel-cisplatin or carboplatin) and 7 patients received the PAC regimen (cisplatin-doxorubicin-cyclophosphamide). The median overall survival of all patients was 42 months, while the breakdown for survival time for patients with PPSPC, MMT and MEC was 44, 13 and 19 months, respectively. The expressions of p53, Top2alpha and Ki-67 were all demonstrated in 11 cases respectively. None showed the expression of Her-2/neu. There were significant differences in the median survival between patients with PPSPC and those with MMMT (44 months vs 13 months, P<0.05), also between patients receiving TP combination and those receiving the PAC regimen (75 months vs 28 months, P<0.05). Another significant difference in the median progression-free survival (PFS) was identified between patients with positive p53 immunostaining and those with negative p53 immunostaining (15 months vs 47 months, P<0.05), whereas age, menopausal status, residual tumor size and the other molecular factors did not significantly impact survival.</p><p><b>CONCLUSION</b>Patients with PPC should be treated with a comprehensive management plan including appropriate cytoreductive surgery and responsive chemotherapy. Overestimating an optimal debulking surgery may not benefit survival. The pathologic subtype, chemotherapy regimen and p53 overexpression were significant prognostic factors.</p>

Tumores müllerianos mixtos de cuello uterino / Mullerian mixed tumors of the uterine cervix

Objetivo: Presentar 3 casos clínicos de tumores müllerianos mixtos de cuello uterino más revisión de la literatura. Método: Análisis retrospectivo de fichas clínicas desde noviembre de 1997 hasta enero de 2005 y revisión de las placas histológicas. Resultados: El rango de edad de las pacientes fue de 36 a 56 años (promedio: 48,3 años). El principal motivo de consulta fue la genitorragia. Al examen clínico presentaban un cuello uterino tumoral de gran volumen (5 a 7 cm). En dos pacientes se identificó un carcinosarcoma, en la otra paciente se diagnosticó un adenosarcoma. Al momento del diagnóstico no presentaban enfermedad extrapelviana evidente. Se realizó histerectomía radical y radioterapia pelviana más braquiterapia postoperatoria en todas ellas. Dos pacientes fallecen con enfermedad extrapelviana a los 11 y 20 meses de seguimiento. La otra paciente esta libre de enfermedad a los 48 meses de seguimiento. Conclusión: Los tumores müllerianos mixtos de cuello uterino son raros, de mal pronóstico cuyo tratamiento principal es la cirugía radical con radioterapia adyuvante en caso de enfermedad localmente avanzada. En casos confinados al cuello uterino se puede lograr una mayor sobrevida libre de enfermedad.

Objective: 3 clinical cases of mixed müllerian tumors of uterine cervix and a literature review are presented. Method: Retrospective analysis of clinical charts and pathological reports between November 1997 and January 2005. Results: Patients' ages ranged from 36 to 56 years (mean: 48,3 years). Abnormal vaginal bleeding was the most common presenting symptom. Pelvic examination revealed a large cervical mass (5 to 7 cm) in all cases. Two patients presented a carcinosarcoma, the other one an adenosarcoma tumor. At the initial diagnosis there were not evidence of extrapelvic disease. Radical hysterectomy and external beam radiation therapy and brachytherapy was performed in all cases. Two patients died with extrapelvic metasta-ses at 11 and 20 months of follow-up. The other one remains without evidence of recurrence 48 months after her treatment. Conclusion: Cervical mixed müllerian tumors are rare and poor prognosis neoplasms, radical surgery and adjuvant radiation therapy for local bulky disease are the optimal therapy. Long-term survival is possible in cervix confined early stage disease.

Post-irradiation carcinosarcoma of uterus--a case report.

The carcinosarcoma (malignant mixed mullerian tumour) of uterus is an aggressive neoplasm composing of malignant glands in the malignant stroma showing biphasic appearance. A 55 year old woman presented with discharge per vaginum of one month duration. Earlier she was given radiotherapy for squamous cell carcinoma of vulva, six years back. Abdominal examination was insignificant. USG suggested presence of post-radiation effect with uterine mass. Panhysterectomy was done and on histopathology, the diagnosis of carcinosarcoma (heterologous variant) was made. The case is being reported and discussed.

Adenosarcoma mülleriano del útero: reporte de un caso / Müllerian adenosarcoma of the uterus: case report

Paciente de 27 años, nuligesta, consultó por sangrado genital irregular de aproximadamente 4 meses de evolución. El examen ginecológico reveló una masa blanda que salió a través del orificio cervical externo. En la ecografía pélvica se evidenció útero aumentado de tamaño, con cavidad uterinaocupada por masas amorfas con pequeñas áreas anecoicas-ecolúcidas en su interior. El informe de anatomía patológica indicó tumor mülleriano mixto, polipoide, benigno tipo adenofibroma de origenendometrial. A los 3 meses, la paciente presentó reaparición de la sintomatología por lo cual se decide prepararla para realizarle histerectomía. Durante este período ingresa con diagnóstico de abdomen agudo quirúrgico, obstrucción intestinal y deshidratación moderada, realizándose histerectomía total ampliada y ooforosalpingectomía bilateral más omentectomía. El informe de anatomía patológica reportó adenosarcoma mülleriano de origen endometrial

Malignant mixed mullerian tumour of the fallopian tube of heterologous variety--a case report.

A female aged 49 years presented with pain and progressive swelling of right lower abdomen. She was operated upon and gross examination revealed a proliferative growth in the fimbrial end of the right fallopian tube. Microscopically the tumour comprised of adenocarcinoma and component of spindle cell stromal sarcoma with areas of chondrosarcoma as heterologous element. A diagnosis of malignant mixed mullerian tumour of the fallopian tube, clinically FIGO stage III was made, which is extremely rare in available literature.

Aspectos reprodutivos em mulheres com malformações mullerianas: a propósito de um caso de útero didelfo / Reproductive aspects in women with mullerian deffects: one case of didelfo uterus

Objetivo: Relatar caso de mulher portadora de malformação mulleriana, considerando sua vida reprodutora e eventuais complicações. Casuística e Método: Descrever a evolução de mulher portadora de anomalia mullheriana, com base em seus antecedentes obstétrícos e discutir, com essas informações e análise da literatura pertinente, quais as influências...